Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma.
Sareddy GR, Li X, Liu J, Viswanadhapalli S, Garcia L, Gruslova A, Cavazos D, Garcia M, Strom AM, Gustafsson JA, Tekmal RR, Brenner A, Vadlamudi RK.
Sareddy GR, et al. Among authors: brenner a.
Sci Rep. 2016 Apr 29;6:24185. doi: 10.1038/srep24185.
Sci Rep. 2016.
PMID: 27126081
Free PMC article.